DS
PRVL

DRW Securities’s Prevail Therapeutics Inc. Common Stock PRVL Stock Holding History

DRW Securities’s Portfolio PRVL Stock Details PRVL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-49,426
Closed -$652K – 158
2019
Q2 		$652K Buy
+49,426
New +$652K 0.04% 46